nimbolide has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ram, AK; Srinivas, BH; Vairappan, B | 2 |
| Hsieh, YH; Hsueh, KC; Lin, CL; Tung, JN; Yang, SF | 1 |
3 other study(ies) available for nimbolide and Liver Neoplasms
| Article | Year |
|---|---|
Nimbolide attenuates gut dysbiosis and prevents bacterial translocation by improving intestinal barrier integrity and ameliorating inflammation in hepatocellular carcinoma.
Topics: Animals; Bacterial Translocation; Carcinoma, Hepatocellular; Dysbiosis; Inflammation; Limonins; Liver Neoplasms; Mice | 2022 |
Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Inflammation; Limonins; Liver Neoplasms; Male; Mice; Molecular Docking Simulation; NF-kappa B; Tight Junction Proteins | 2020 |
Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Heterografts; Humans; Limonins; Liver Neoplasms; Male; Mice, Nude; Neoplasm Transplantation | 2018 |